
Teva’s CEO shares ‘Pivot to Growth’ progress
The Top Line
00:00
Teva's Innovative Transformation
This chapter highlights Teva's strategic efforts to enhance its portfolio of innovative medicines, focusing on key products like Osteto and Ajovi. It emphasizes the company's commitment to addressing unmet medical needs in conditions such as tardive dyskinesia and schizophrenia, and discusses strategies to improve patient awareness and outcomes.
Transcript
Play full episode